Curis
CRIS
#11106
Rank
S$0.86 M
Marketcap
S$0.44
Share price
-17.89%
Change (1 day)
-78.44%
Change (1 year)

Curis (CRIS) - Cash on Hand

Cash on Hand as of March 2026 : S$19.23 Million

According to Curis's latest financial reports the company has S$19.23 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Curis - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$6.49 M-76.09%
2024-12-31S$27.18 M-63.47%
2023-12-31S$74.4 M-35.18%
2022-12-31S$0.11 B-26.73%
2021-12-31S$0.15 B-29.72%
2020-12-31S$0.22 B704.85%
2019-12-31S$27.69 M-16.47%
2018-12-31S$33.15 M-58.84%
2017-12-31S$80.56 M25.13%
2016-12-31S$64.38 M-44.62%
2015-12-31S$0.11 B76.86%
2014-12-31S$65.73 M-10.82%
2013-12-31S$73.71 M8.53%
2012-12-31S$67.91 M39.05%
2011-12-31S$48.84 M-6.6%
2010-12-31S$52.29 M47.52%
2009-12-31S$35.44 M-14.09%
2008-12-31S$41.26 M-30.84%
2007-12-31S$59.65 M6.14%
2006-12-31S$56.2 M-23.64%
2005-12-31S$73.6 M-8.87%
2004-12-31S$80.77 M34.54%
2003-12-31S$60.04 M-15.55%
2002-12-31S$71.1 M-26.29%
2001-12-31S$96.46 M-25.86%
2000-12-31S$0.13 B265.65%
1999-12-31S$35.58 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
S$16.76 B 87,060.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.44 B 69,802.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$71.99 M 274.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$0.99 B 5,081.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.57 B 2,909.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$2.42 M-87.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.20 B 968.60%๐Ÿ‡บ๐Ÿ‡ธ USA